Journals / Çocuk Dergisi / 2026 / Cilt: 25 Sayı: 3

Use of Meropenem in Children Labeled with Penicillin and Cephalosporin Allergy: A Retrospective Study Based on Reallife Data

Merve Karaca Şahin(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0000-0001-8783-0514
Güler Yıldırım(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0000-0001-7852-9252
Nilay Çalışkan(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0000-0002-5546-0034
Hamit Boloğur(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0000-0003-1092-8833
Muhammed Fatih Erbay(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0000-0002-4128-3081
Aslı Berivan Topçak(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0009-0007-8300-6430
Hasan Tunç Şarman(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0009-0000-7234-5516
Hilal Güngör(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0000-0002-8923-1897
Çağla Öztürk(BEZMI ALEM FOUNDATION UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0000-0002-8645-0373
Şefika İlknur Kökçü Karadağ(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0000-0001-9234-633X
Deniz Özçeker(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL OKMEYDANI HEALTH RESEARCH CENTER, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CHILD HEALTH AND DISEASES, PEDIATRIC IMMUNOLOGY AND ALLERGIC DISEASES)0000-0002-0032-6727
Pages
136–143
Publication Date
2025-10-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Meropenem appears to be a safe and effective alternative treatment option for patients labeled with beta-lactam allergy until a comprehensive beta-lactam allergy workup can be conducted.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Beta-lactam antibiotics are among the most commonly used and frequently reported drug allergies.
📊
Key Findings & Data:However, recent publications demonstrate that side chains, rather than the beta-lactam ring, are primarily responsible for cross-reactivity and that meropenem can be safely used in patients with beta-lactam allergies.
💡
Conclusion & Impact:Conclusion: Meropenem appears to be a safe and effective alternative treatment option for patients labeled with beta-lactam allergy until a comprehensive beta-lactam allergy workup can be conducted.
🔬Design:Araştırma Makalesi
📍Scope:2017 Verileri
⚙️Variables:Beta-lactam · Drug hypersensitivity · Meropenem

Abstract

Objective: Beta-lactam antibiotics are among the most commonly used and frequently reported drug allergies. The beta-lactam ring has traditionally been considered to be responsible for cross-reactivity across all betalactam antibiotics. However, recent publications demonstrate that side chains, rather than the beta-lactam ring, are primarily responsible for cross-reactivity and that meropenem can be safely used in patients with beta-lactam allergies. The aim of our study was to evaluate the safety of meropenem in patients labeled with penicillin and cephalosporin allergies based on real-life data. Materials and Methods: Children under the age of 18 years who were referred to the Pediatric Immunology and Allergy with a beta-lactam allergy label between January 1, 2017, and September 1, 2024, were retrospectively evaluated. Results: A total of 95 children labeled with a beta-lactam allergy were referred to our Pediatric Allergy and Immunology Clinic for appropriate antibiotic selection. Among them, 64% were female and 36% were male. Fiftyeight patients were labeled as allergic to penicillins only, 31 to cephalosporins only, and 6 to both drug classes. Meropenem was administered to 23 patients. Of these, only three developed a rash following meropenem treatment and were re-referred for further evaluation. A total of 15 patients presented to our outpatient clinic for the diagnostic assessment of beta-lactam allergy. None of them had an allergy to meropenem. However, beta-lactam allergy was confirmed in three patients. Conclusion: Meropenem appears to be a safe and effective alternative treatment option for patients labeled with beta-lactam allergy until a comprehensive beta-lactam allergy workup can be conducted.

🔖

Cite This Article

Şahin, M. K., Yıldırım, G., Çalışkan, N., Boloğur, H., Erbay, M. F., Topçak, A. B., Şarman, H. T., Güngör, H., Öztürk, Ç., Karadağ, Ş. İ. K., Özçeker, D. (2025). Use of Meropenem in Children Labeled with Penicillin and Cephalosporin Allergy: A Retrospective Study Based on Reallife Data. Çocuk Dergisi, Cilt: 25 Sayı: 3, 136–143. https://doi.org/10.26650/jchild.2025.1725683

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (31)

  1. Brauer R, Ruigömez A, Downey G, Bate A, Garcia Rodriguez LA, Huerta C et al. Prevalence of antibiotic use: a comparison across various European health care data sources Pharmacoepidemiol Drug Saf. 2016 Mar 7;25(S1):11-2O. google scholar
  2. Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca-Lopez N et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy. 2016 Feb 17;71(2):149-61. google scholar
  3. Montanez MI, Ariza A, Mayorga C, Fernandez TD, Torres MJ. Cross-reactivity in betalactam allergy: alternative treatments. Curr Treat Options Allergy. 2015 Jun 28;2(2):141-54. google scholar
  4. Steffens NA, Zimmermann ES, Nichelle SM, Brucker N. Meropenem use and therapeutic drug monitoring in clinical practice: a literature review J Clin Pharm Ther. 2021 Jun 3;46(3):610-21. google scholar
  5. Romano A, Gaeta F, Poves MFA, Valluzzi RL. Cross-reactivity among beta-lactams. Curr Allergy Asthma Rep. 2016 Mar 22;16(3):24. google scholar
  6. Sâenz de Santa Marıa R, Bogas G, Labella M, Ariza A, Salas M, Dona I et al. Approach for relabeling beta-lactam allergy in children Frontiers in Allergy. 2023 Nov 15;4. google scholar
  7. Yilmaz Topal O, Kulhas Celik I, Turgay Yagmur I, Toyran M, Civelek E, Karaatmaca B et al. Evaluation of the Clinical Properties and Diagnostic Test Results of Cephalosporin Allergy in Children Int Arch Allergy Immunol. 2021;182(8):709-15. google scholar
  8. Erkoçoğlu M, Kaya A, Civelek E, Özcan C, Çakır B, Akan A et al. Prevalence of confirmed immediate-type drug hypersensitivity reactions among school children Pediatric Allergy and Immunology. 2013;24(2):160-7. google scholar
  9. Picard M, Robitaille G, Karam F, Daigle JM, Bedard F, Biron E, et al. Cross-reactivity to cephalosporins and carbapenems in penicillin-allergic patients: two systematic reviews and meta-analyses. J Allergy Clin Immunol Pract. 2019;7(8):2722-2738.e5. google scholar
  10. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations Allergy. 2003;58(9):854-63. google scholar
  11. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions Curr Opin Allergy Clin Immunol. 2005;5(4):309-16. google scholar
  12. Vyles D, Chiu A, Simpson P, Nimmer M, Adams J, Brousseau DC. Parent-reported penicillin allergy symptoms in the pediatric emergency department. Acad Pediatr. 2017 Apr;17(3):251-5. google scholar
  13. Caubet JC, Kaiser L, Lemaître B, Fellay B, Gervaix A, Eigenmann PA. The role of penicillin in benign skin rashes in childhood: A prospective study based on drug rechallenge Journal of Allergy and Clinical Immunology. 2011;127(l):218-22. Torres-Rojas I, Perez-Alzate D, Somoza ML, Pfeifer APM, Diaz EH, Jimenez-Rodriguez TW, et al. Clavulanic Acid is a leading culprit beta-lactam in immediate allergic reactions to penicillins. Allergy Asthma Immunol Res. 2023;15(2):201. google scholar
  14. Torres-Rojas I, Pérez-Alzate D, Somoza ML, Pfeifer APM, Diaz EH, JimenezRodriguez TW, et al. Clavulanic Acid is a leading culprit beta-lactam in immediate allergic reactions to penicillins. Allergy Asthma Immunol Res. 2023;15(2):201. google scholar
  15. Casimir-Brown RS, Kennard L, Kayode OS, Siew LQC, Makris M, Tsilochristou O et al. Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis. J Allergy Clin Immunol Pract. 2021 May;9(5):2001-9. google scholar
  16. Zagursky RJ, Pichichero ME. Cross-reactivity in p-Lactam Allergy. J Allergy Clin Immunol Pract. 2018;6(1):72-81.e1. google scholar
  17. Lucas M, Arnold A, Sommerfield A, Trevenen M, Braconnier L, Schilling A et al. Antibiotic Allergy Labels in Children Are Associated with Adverse Clinical Outcomes J Allergy Clin Immunol Pract. 2019;7(3):975-82. google scholar
  18. van Dijk SM, Gardarsdottir H, Wassenberg MWM, Oosterheert JJ, de Groot MCH, Rockmann H. The High Impact of Penicillin Allergy Registration in Hospitalized Patients J Allergy Clin Immunol Pract. 2016 Sep;4(5):926-31. google scholar
  19. Charneski L, Deshpande G, Smith SW. Impact of an Antimicrobial Allergy Label in the Medical Record on Clinical Outcomes in Hospitalized Patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2011 Aug 6;3l(8):742-7. google scholar
  20. Armitage KF, Porter CE, Ahmed S, Cook J, Boards J, Bongard E et al. Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomized pragmatic trial. BMJ Open. 2023 Sep 4;13(9):e072253. google scholar
  21. Mir A, Lanoue D, Zanichelli V, van Walraven C, Olynych T, Nott C et al. Introduction of a penicillin allergy de-labeling program with direct oral challenge and its effects on use of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study Allergy, Asthma & Clinical Immunology. 2024 Mar 5;20(1):20. google scholar
  22. Ali S, Hughes T, Smith A. Long waitlists for outpatient drug allergy referrals: An Australian tertiary center experience. World Allergy Organization Journal. 2024 Feb;17(2):100863. google scholar
  23. Savic L, Ardern-Jones M, Avery A, Cook T, Denman S, Farooque S, et al. BSACI guideline for the set-up of penicillin allergy de-labelling services by non-allergists working in a hospital setting. Clinical and Experimental Allergy. 2022 Oct 21;52(1O):1135-41. google scholar
  24. Blumenthal KG, Wickner PG, Hurwitz S, Pricco N, Nee AE, Laskowski K et al. Tackling inpatient penicillin allergies: Assessing tools for antimicrobial stewardship. Journal of Allergy and Clinical Immunology. 2017;140(1):154-161.e6. google scholar
  25. Romano A, Atanaskovic-Markovic M, Barbaud A, Bircher AJ, Brockow K, Caubet J et al. Toward a more precise diagnosis of hypersensitivity to beta-lactams — an EAACI position paper. Allergy. 2020 Jun 29;75(6):1300-15. google scholar
  26. Romano A, Viola M, Gueant-Rodriguez RM, Gaeta F, Valluzzi R, Gueant JL. Brief Communication: Tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins Ann Intern Med. 2007 Feb 20;146(4):266-9. google scholar
  27. Atanaskovic-Markovic M, Gaeta F, Medjo B, Viola M, Nestorovic B, Romano A. Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins Allergy. 2008 Feb 4;63(2):237-40. google scholar
  28. Wall GC, Nayima VA, Neumeister KM. Assessment of hypersensitivity reactions in patients receiving carbapenem antibiotics who report a history of penicillin allergy Journal of Chemotherapy. 2014 Jun 6;26(3):150-3. google scholar
  29. Sodhi M, Axtell SS, Callahan J, Shekar R. Is it safe to use carbapenems in patients with a history of allergy to penicillin? J Antimicrob Chemother. 2004;54(6):1155-7. google scholar
  30. Cunha BA, Hamid NS, Krol V, Eisenstein L. Safety of Meropenem in Patients Reporting Penicillin Allergy: Lack of Allergic Cross Reactions Journal of Chemotherapy. 2008 Apr 18;20(2):233–7. google scholar
  31. Torres MJ, Adkinson NF, Caubet JC, Khan DA, Kidon MI, Mendelson L et al. Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing J Allergy Clin Immunol Pract. 2019;7(1):40–5. google scholar